Nalfurafine
Top View
- Customs Tariff - Schedule
- Preclinical Testing of Nalfurafine As an Opioid-Sparing Adjuvant That Potentiates Analgesia by the Mu Opioid Receptor-Targeting Agonist Morphine*
- Report on the Deliberation Results November 6, 2008 Evaluation And
- The Κ-Opioid Receptor Agonist Nalfurafine
- The Study of Pain in Rats and Mice
- PROGRAM BOOK Table of Contents
- Investigating the Anti-Cocaine, Anti-Nociceptive Properties and Side Effects of MP1104, a Novel Mixed Opioid Receptor Agonist
- Anatomical Classification Guidelines V2018 EPHMRA ANATOMICAL
- Kappa;-Opioid Receptor Activation in Dopamine Neurons
- Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
- Atc Index 2010
- Sex Differences in Kappa Opioid Pharmacology
- Effects of Kappa Opioid Receptor Agonists on Fentanyl Vs
- Advances in Achieving Opioid Analgesia Without Side Effects
- Annual Report 2008 Page 2/158 EMEA/330566/2009 6.4 EMEA Document Management and Publishing ______81 ANNEXES
- Annual Report 2013
- Winfuran, INN-Nalfurafine
- Nalfurafine Hydrochloride, a Selective Κ Opioid